SCHEMBL11743535

SCHEMBL11743535

C[S+]([O-])c1ccc(-c2nnc(N(OCCO)OCCO)nc2-c2ccc([S+](C)[O-])cc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11747999 0.81 PTGES (0.43) —
SCHEMBL11741002 0.80 SLC29A1 (0.35) —
SCHEMBL11745513 0.80 CA12 (0.33) —
SCHEMBL11749947 0.77 NUDT1 (0.35) —
SCHEMBL11746332 0.77 — —
SCHEMBL11747846 0.77 SLC29A1 (0.32) —
SCHEMBL11744957 0.75 RAD51 (0.30) —
SCHEMBL11748724 0.75 RAD51 (0.30) —
SCHEMBL11748846 0.74 POLB (0.30) —
SCHEMBL11743524 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4008232-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1977-02-15 — — US disclosed
US-3979516-A Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines ELI LILLY AND COMPANY (US) 1976-09-07 — — US disclosed
US-3948894-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1976-04-06 — — US disclosed
Send feedback